Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

11.48 +0.88 (+8.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Insights Ahead: NeoGenomics's Quarterly Earnings ↗

April 28, 2025

Via Benzinga

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

April 28, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting earnings tomorrow morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

April 22, 2025

From NeoGenomics, Inc.

Via Business Wire

Deep Dive Into NeoGenomics Stock: Analyst Perspectives (5 Ratings) ↗

April 17, 2025

Via Benzinga

Demystifying NeoGenomics: Insights From 6 Analyst Reviews ↗

February 19, 2025

Via Benzinga

5 Analysts Assess NeoGenomics: What You Need To Know ↗

January 15, 2025

Via Benzinga

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

April 08, 2025

From NeoGenomics, Inc.

Via Business Wire

Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

April 08, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting...

Via StockStory

NeoGenomics Completes Acquisition of Pathline

April 07, 2025

From NeoGenomics, Inc.

Via Business Wire

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

April 03, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including NeoGenomics (NASDAQ:NEO) and its peers.

Via StockStory

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

April 01, 2025

From NeoGenomics, Inc.

Via Business Wire

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

March 27, 2025

Looking back on testing & diagnostics services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers.

Via StockStory

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

March 26, 2025

Via StockStory

3 Reasons to Sell NEO and 1 Stock to Buy Instead

March 21, 2025

NeoGenomics has gotten torched over the last six months - since September 2024, its stock price has dropped 36.8% to $9.98 per share. This may have investors wondering how to approach the situation.

Via StockStory

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

March 18, 2025

From NeoGenomics, Inc.

Via Business Wire

Earnings Scheduled For March 18, 2025 ↗

March 18, 2025

Via Benzinga

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

March 14, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Quest (NYSE:DGX) and the best and worst...

Via StockStory

3 Small-Cap Stocks in Hot Water

March 12, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

March 10, 2025

From NeoGenomics, Inc.

Via Business Wire

3 Healthcare Stocks Skating on Thin Ice

February 28, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

What To Expect From RadNet’s (RDNT) Q4 Earnings

February 26, 2025

Diagnostic imaging company RadNet (NASDAQ:RDNT) will be reporting results tomorrow after market hours. Here’s what to look for.

Via StockStory

NeoGenomics to Participate in Upcoming Investor Conferences

February 24, 2025

From NeoGenomics, Inc.

Via Business Wire

Why NeoGenomics (NEO) Shares Are Trading Lower Today

February 18, 2025

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 21.5% in the afternoon session after the company reported weak fourth-quarter results, with revenue falling below Wall...

Via StockStory

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

February 18, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 10.6% year on year to $172 million. On the other hand, the...

Via StockStory

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

February 18, 2025

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

February 17, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results tomorrow morning. Here’s what to look for.

Via StockStory

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

January 29, 2025

From NeoGenomics, Inc.

Via Business Wire

Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review ↗

January 17, 2025

Many stocks flashed buy signals as the major indexes rose to or above key levels.

Via Investor's Business Daily

Topics Economy

Earnings Scheduled For February 18, 2025 ↗

February 18, 2025

Via Benzinga

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance ↗

January 15, 2025

The company expects sales to grow 12% to 13% annually in the long term.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

NeoGenomics, Inc. - Common Stock (NQ:NEO)

All News about NeoGenomics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today